Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15585832rdf:typepubmed:Citationlld:pubmed
pubmed-article:15585832lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0546816lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C1306235lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0920421lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0348011lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0152060lld:lifeskim
pubmed-article:15585832lifeskim:mentionsumls-concept:C0205154lld:lifeskim
pubmed-article:15585832pubmed:issue12lld:pubmed
pubmed-article:15585832pubmed:dateCreated2004-12-8lld:pubmed
pubmed-article:15585832pubmed:abstractTextThe lack of persistence of transferred autologous mature lymphocytes in humans has been a major limitation to the application of effective cell transfer therapies. The results of a pilot clinical trial in 13 patients with metastatic melanoma suggested that conditioning with nonmyeloablative chemotherapy before adoptive transfer of activated tumor-reactive T cells enhances tumor regression and increases the overall rates of objective clinical responses. The present report examines the relationship between T cell persistence and tumor regression through analysis of the TCR beta-chain V region gene products expressed in samples obtained from 25 patients treated with this protocol. Sequence analysis demonstrated that there was a significant correlation between tumor regression and the degree of persistence in peripheral blood of adoptively transferred T cell clones, suggesting that inadequate T cell persistence may represent a major factor limiting responses to adoptive immunotherapy.lld:pubmed
pubmed-article:15585832pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:languageenglld:pubmed
pubmed-article:15585832pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15585832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15585832pubmed:statusMEDLINElld:pubmed
pubmed-article:15585832pubmed:monthDeclld:pubmed
pubmed-article:15585832pubmed:issn0022-1767lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:RosenbergStev...lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:DudleyMark...lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:El-GamilMonaMlld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:RobbinsPaul...lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:ZhouJuhuaJlld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:LiYong FYFlld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:PowellDaniel...lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:HuangJianping...lld:pubmed
pubmed-article:15585832pubmed:authorpubmed-author:WunderlichJoh...lld:pubmed
pubmed-article:15585832pubmed:issnTypePrintlld:pubmed
pubmed-article:15585832pubmed:day15lld:pubmed
pubmed-article:15585832pubmed:volume173lld:pubmed
pubmed-article:15585832pubmed:ownerNLMlld:pubmed
pubmed-article:15585832pubmed:authorsCompleteYlld:pubmed
pubmed-article:15585832pubmed:pagination7125-30lld:pubmed
pubmed-article:15585832pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:meshHeadingpubmed-meshheading:15585832...lld:pubmed
pubmed-article:15585832pubmed:year2004lld:pubmed
pubmed-article:15585832pubmed:articleTitleCutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.lld:pubmed
pubmed-article:15585832pubmed:affiliationSurgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Paul_Robbins@nih.govlld:pubmed
pubmed-article:15585832pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15585832pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15585832pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15585832lld:pubmed
More...